Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Endocrinol. 2011 Dec 19;212(3):327–342. doi: 10.1530/JOE-11-0300

Figure 1. Maternal (A) and Fetal (B) Plasma Glucose Concentrations.

Figure 1

Sustained mild (mPHG) or moderate (PHG) hyperglycemia was initiated on day 0. Plasma was sampled prior to initiating treatment on day 0 and prior to the 0800 dextrose pulse daily thereafter. Panel C shows maternal and fetal plasma glucose concentrations during the 45-min dextrose pulse administered at 1400 on day 9 of treatment. The two-hour sampling period illustrates the magnitude and duration of hyperglycemia resulting from one of the dextrose pulses, which were given 3x/day throughout the treatment period.